MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-06-0008447
Sreeven Pharma Private Limited
Sreeven Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.92 Cr
▲ 284% YoY
Net loss · FY 2025
₹3.15 Cr
Net margin -164.6%
EBITDA · FY 2025
-₹2.45 Cr
EBITDA margin -127.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.69 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹9.06 Cr
Company age
34 yrs
Est. 1992
Directors on board
2
As per MCA filings
About Sreeven Pharma Private Limited
Data last updated:
Sreeven Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U65993TG1992PTC014481. Its GSTIN is 29AAICS9525P1ZD (Karnataka).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.69 Cr. It was formerly known as Richie Investments & Consultants Pvt Ltd. It is led by directors Devendrappa Jegashetty (Managing Director) and Sandeep Gokaraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.92 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.15 Cr (net margin -164.6%) and EBITDA of -₹2.45 Cr (EBITDA margin -127.8%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹9.06 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
Sreeven Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0008447). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Sreeven Pharma Private Limited
CIN U65993TG1992PTC014481
Registration Number 014481
Incorporation Date 08 July 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-06-0008447
CIN History of Sreeven Pharma Private Limited
Sreeven Pharma has one previous CIN (Corporate Identification Number): U65993AP1992PTC014481. The current CIN is U65993TG1992PTC014481, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U65993TG1992PTC014481 | Current |
| U65993AP1992PTC014481 | Previous |
Recognitions & Rankings of Sreeven Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. 11 – 15 – 25 Doctors Colony Lb Nagar, Hyderabad, Telangana, India – 500074
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Sreeven Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Sreeven Pharma Private Limited
The main business activity of Sreeven Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sreeven Pharma Private Limited FY 2025 filings available
Sreeven Pharma Private Limited reported revenue of ₹1.92 Cr (up 284% YoY) for FY 2025.
Revenue · FY 2025
₹1.92 Cr ▲ 284%
Net loss · FY 2025
₹3.15 Cr margin -164.6%
EBITDA · FY 2025
-₹2.45 Cr margin -127.8%
Compounded Annual Growth Rate (CAGR) of Sreeven Pharma Private Limited
Revenue CAGR growth
1 year
▲ 284%
3 years · compounded
▼ 24%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 76%
3 years · compounded
▼ 103%
5 years · compounded
▼ 83%
Revenue rose 284% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sreeven Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.45 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.15 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sreeven Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -127.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -164.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sreeven Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sreeven Pharma Private Limited
Sreeven Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Gokaraju Also directs: Tyche Industries Limited, Sirona Life Sciences Private Limited | Director | 15 Jul 2022 | 4 Years 3 Months | Current |
| Devendrappa Jegashetty | Managing Director | 11 Apr 2003 | 23 Years 6 Months | Current |
Peer Comparison of Sreeven Pharma Private Limited
Sreeven Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lykmi Healthcare Private Limited | ₹1.94 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Dashak Pharmaceuticals Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Chandigarh U.T, Chandigarh, India |
| MP Laboratories Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Chennai, Tamil Nadu, India |
| Medo Specia Pharma Private Limited | ₹1.92 Cr (FY 2021) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Meliorate Health Private Limited | ₹1.92 Cr (FY 2023) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Sreeven Pharma Private Limited this company | ₹1.92 Cr (FY 2025) | •••• | •••• | 284.0% | •••• | Hyderabad, Telangana, India |
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 399.0% | •••• | Ahmedabad, Gujarat, India |
| Zenith Chemical Works Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Rege Engredea Private Limited | ₹1.91 Cr (FY 2018) | •••• | •••• | •••• | Nalgonda, Telangana, India | |
| Kan India Realtors Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Thane, Maharashtra, India |
| Laurel Pharmaceuticals Pvt Ltd | ₹1.91 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Jalandhar, Punjab, India |
Peers are the five companies nearest above and the five nearest below Sreeven Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sreeven Pharma Private Limited
Sreeven Pharma Private Limited is audited by Meenavali & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Meenavali & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sreeven Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sreeven Pharma Private Limited
Open charges
₹6 Cr
Satisfied charges
₹9.06 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2024 | Axis Bank Limited | ₹6 Cr | Open |
| 27 Jan 2017 | Syndicate Bank | ₹1.2 Cr | Satisfied |
| 22 Feb 2016 | Canara Bank | ₹4.95 Cr | Satisfied |
| 26 Aug 2011 | Axis Bank Limited | ₹2.21 Cr | Satisfied |
| 31 Oct 2008 | Syndicate Bank | ₹70 Lakh | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Sreeven Pharma Private Limited
Sreeven Pharma Private Limited has 2 court cases on record: 2 filed by Sreeven Pharma. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against State of Karnataka | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Sreeven Pharma Private Limited
Sreeven Pharma Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 48 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mallikarjuna Pharma | •••• | •••• | •••• |
| Dhanasri Enterprises | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| LCGC Chrom Consumables LLP | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Sreeven Pharma Private Limited
Employment history and EPFO contributions of people linked to Sreeven Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sreeven Pharma Private Limited
Sreeven Pharma Private Limited has 8 board changes on record since 2003: 2 appointments and 6 cessations. The latest: Jegashette Vijaya Laxmi ceased to be Director on 22 Apr 2024.
AGM
Sreeven Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sreeven Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100972431 was registered on 19 Aug 2024.
Ceased
Jegashette Vijaya Laxmi ceased to be Director.
Ceased
Suryakanth Patil ceased to be Director.
Charges
A charge registered on 27 Jan 2017 via Charge ID 100083574 with Syndicate Bank was fully satisfied on 10 Oct 2022.
Charges
A charge registered on 22 Feb 2016 via Charge ID 10627736 with Canara Bank was fully satisfied on 10 Oct 2022.
Ceased
Sandeep Gokaraju ceased to be Additional Director.
Appointed
Sandeep Gokaraju was appointed as Director.
Charges
A charge with Canara Bank of Rs. 4.95 Cr registered on 22 Feb 2016 with Charge ID 10627736 was modified on 09 Jul 2020.
Charges
A charge with Syndicate Bank amounted to Rs. 1.20 Cr with Charge ID 100083574 was registered on 27 Jan 2017.
Charges
A charge with Canara Bank amounted to Rs. 4.95 Cr with Charge ID 10627736 was registered on 22 Feb 2016.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sreeven Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sreeven Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sreeven Pharma Private Limited
Sreeven Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICS9525P1ZD | Karnataka | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sreeven Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sreeven Pharma Private Limited
Sreeven Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 1992 (34+ years old) and is registered under CIN U65993TG1992PTC014481.
Sreeven Pharma reported revenue of ₹1.92 Cr for FY 2025 (up 284% YoY).
Sreeven Pharma has 2 current directors:
- Devendrappa Jegashetty - Managing Director
- Sandeep Gokaraju - Director
Sreeven Pharma reported a net loss of ₹3.15 Cr (net margin -164.6%) and EBITDA of -₹2.45 Cr (EBITDA margin -127.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sreeven Pharma is -24% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 284%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sreeven Pharma is 29AAICS9525P1ZD, registered in Karnataka.
The CIN (Corporate Identification Number) of Sreeven Pharma is U65993TG1992PTC014481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sreeven Pharma has 2 court cases on record: 2 filed by the company.
Sreeven Pharma was incorporated on 08 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sreeven Pharma by revenue are Lykmi Healthcare Private Limited, Dashak Pharmaceuticals Private Limited, MP Laboratories Private Limited, Medo Specia Pharma Private Limited, Meliorate Health Private Limited and 5 more, all in the Pharma industry (Formulations).
Jegashette Vijaya Laxmi ceased to be Director on 22 Apr 2024. Suryakanth Patil ceased to be Director on 22 Apr 2024. Sandeep Gokaraju ceased to be Additional Director on 30 Sep 2022. Sreeven Pharma has 8 board changes on record in total.
Yes, Sreeven Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-06-0008447).